Skip to content

Effects of Fruit Extracts on Glycaemia: The GLU-FRU Study

The Acute Effects of Blackcurrant and Apple Extracts on Postprandial Glycaemia: a Randomised Controlled Trial. The GLU-FRU Study

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02340039
Acronym
GLU-FRU
Enrollment
34
Registered
2015-01-16
Start date
2015-01-31
Completion date
2015-07-31
Last updated
2019-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Postprandial Hyperglycemia

Keywords

Polyphenol, Fruit, Metabolic

Brief summary

Raised blood glucose levels can lead to adverse modifications to functional proteins within the body and eventually lead to the development of type 2 diabetes. Fruit polyphenols may help to control glycaemia following a carbohydrate meal or beverage. The aim of this study is to investigate the effects of blackcurrant (BC) and apple (A) extracts on postprandial glycaemia, insulinaemia and plasma gastric inhibitory polypeptide concentrations following a mixed carbohydrate test meal.

Detailed description

Introduction: Diets with a high glycaemic load (a measure of the overall blood glucose-raising effect of a serving of a food) and containing high amounts of non-milk extrinsic sugars may contribute towards increased risk of developing type 2 diabetes (T2D). Raised blood glucose levels can lead to adverse modifications to functional proteins within the body and eventually lead to the development of T2D. Large peaks in blood glucose after a meal are a risk factor for T2D, and therefore it is desirable to consume a diet that will allow more gradual rises in blood glucose levels after meals. Fruit polyphenols may help to control glycaemia following a carbohydrate meal or beverage. Possible mechanisms include inhibition of intestinal enzymes and inhibition of intestinal glucose absorption by decreasing SGLT1/GLUT2 transport activity. The scientific literature also suggests that foods rich in polyphenols exert beneficial effects on risk factors of cardiovascular disease such as hypertension, lipid metabolism and vascular function. Study Design: A randomised, controlled, double-blind, cross-over study will be conducted. Subjects will receive combined blackcurrant and apple polyphenols, apple polyphenols only or placebo in random order at 3 separate study visits immediately before a high-carbohydrate meal. Seven days wash-out period will be required between study days.Standardised diet and exercise advice will be given prior to the visit. Subjects will arrive on each study visit between 09.00 and 10.00 h, after a 12 h overnight fast. They will then be cannulated in a forearm vein and baseline fasting blood samples will be taken in duplicate. All test drinks will be blended to be equal in volume, macronutrient and energy content. Fruit extracts instead of whole fruits will be administered to avoid the confounding effect of fruit fibre/viscosity on gastric emptying rate. Following consumption of the test drink, the high carbohydrate meal (starch and sucrose) will be served (white bread with apricot jam). Outcome variables will be measured postprandially until 120 min post-meal.

Interventions

DIETARY_SUPPLEMENTPolyphenols

Drinks will be delivered in random order at 3 separate study visits immediately before a high-carbohydrate meal. Seven days wash-out period will be required between study days.

Sponsors

King's College London
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
20 Years to 60 Years
Healthy volunteers
Yes

Inclusion criteria

* Age: 20-60 y * Male and female (post-menopausal only) * Healthy (free of diagnosed diseases in the

Exclusion criteria

) * BMI 18-35 kg/m2 * Able to understand the information sheet and willing to comply with study protocol * Able to give informed written consent

Design outcomes

Primary

MeasureTime frameDescription
Postprandial glycaemiabaseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.Peak postprandial plasma glucose concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min

Secondary

MeasureTime frameDescription
Postprandial glucose-dependent insulinotropic polypeptide (GIP) concentrationsbaseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.Peak postprandial GIP concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
Postprandial glucagon-like peptide-1 (GLP-1) concentrationsbaseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.Peak postprandial GLP-1 concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
Blood pressurebaseline and 60, 90 and 120 min following the test drink.Change in the blood pressure after consumption of test drink
Postprandial insulinaemiabaseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.Peak postprandial insulin concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
Plasma non-esterified fatty acids (NEFA)baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.Peak postprandial NEFA concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
Plasma triglycerides (TAG)baseline and 10, 20, 30, 45, 60, 75, 90 and 120 min following the test drink.Peak postprandial TAG concentrations (Cmax) t +0-30 min and change from baseline data and areas over baseline t+0-30 min and t+0-120 min
Vascular function (Digital Volume Pulse; DVP)baseline and 60, 90 and 120 min following the test drink.Change in the tone of larger arteries (stiffness index) and small to medium-sized arteries (reflection index).

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026